Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
Clinical trial NCT06208917 · RECRUITING
Trial details
- NCT number
- NCT06208917
- Sponsor
- Yizhuo Zhang
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-09
- Primary completion
- 2026-07-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.